Clinical Trials Browser

Parkinson Disease 4, Autosomal Dominant Lewy Body, Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT06888921 2026-04-01

MAIA-ovarian

Phase 1/2 Recruiting

60 enrolled

Gynecologic

Ovarian Neoplasms

NCT05116189 2026-03-09

KEYNOTE-B96

Phase 3 Active not recruiting

643 enrolled 17 charts 1 FDA

Gynecologic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03635567 2026-02-04

KEYNOTE-826

Phase 3 Completed

617 enrolled 29 charts 1 FDA

Gynecologic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

NCT04199754 2024-05-31

IV Contrast-Enhanced Cone Beam Computed Tomography (CBCT) in Radiotherapy

Phase EARLY_PHASE1 Terminated

6 enrolled

Gynecologic

Pelvic Neoplasms

NCT04065009 2024-01-11

IPLA-OVCA

Phase 3 Active not recruiting

220 enrolled

Gynecologic

Advanced Ovarian Cancer

NCT05794659 2023-07-20

Cornerstone4

Phase 2 Not yet recruiting

98 enrolled

Gynecologic

Advanced Ovarian Cancer

NCT04201561 2023-06-26

SELENIUM

Phase 3 Unknown

68 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peripheral Nervous System Diseases

NCT05560035 2022-09-29

The Effect of Intravenous Lidocaine on THBS2 and Angiogenic Factors Expression in Women Undergoing Cervical Cancer Surgery

Phase NA Unknown

60 enrolled

Gynecologic

Uterine Cervical Neoplasms, Neoplasm Metastasis, Disease Progression

NCT05450055 2022-07-13

Intraperitoneal Lidocaine in Ovarian Cancer Surgery

Phase NA Not yet recruiting

60 enrolled

Gynecologic

Ovarian Neoplasms, Pain, Postoperative

NCT04360629 2022-06-01

Efficacy and Safety of Tranexamic Acid in Cytoreductive Surgery for Ovarian Cancer

Phase NA Completed

151 enrolled

Gynecologic

Advanced Ovarian Cancer

NCT00740116 2022-03-15

Tranexamic Acid in Surgery of Advanced Ovarian Cancer

Phase 4 Completed

100 enrolled 11 charts

Gynecologic

Ovarian Neoplasms, Thromboembolism, Blood Loss, Surgical, Postoperative Hemorrhage

NCT01882920 2017-04-26

Goal Directed Therapy (GDT) in Cytoreductive Surgery (CRS) and Hyperthermic Intra Peritoneal Chemotherapy (Hipec)

Phase NA Completed

80 enrolled

Gynecologic

Primary Peritoneal Neoplasm

NCT00738699 2017-03-30

FAR-122

Phase 2 Terminated

415 enrolled 11 charts

Gynecologic

Ovarian Neoplasms

NCT01432015 2017-03-28

Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting

Phase 4 Completed

20 enrolled 5 charts

Gynecologic

Ovarian Neoplasms, Uterine Neoplasms, Vomiting

NCT01492179 2014-05-28

Clinical Trials

KEYLYNK-001

MAIA-ovarian

KEYNOTE-B96

KEYNOTE-826

IV Contrast-Enhanced Cone Beam Computed Tomography (CBCT) in Radiotherapy

IPLA-OVCA

Cornerstone4

SELENIUM

The Effect of Intravenous Lidocaine on THBS2 and Angiogenic Factors Expression in Women Undergoing Cervical Cancer Surgery

Intraperitoneal Lidocaine in Ovarian Cancer Surgery

Efficacy and Safety of Tranexamic Acid in Cytoreductive Surgery for Ovarian Cancer

Tranexamic Acid in Surgery of Advanced Ovarian Cancer

Goal Directed Therapy (GDT) in Cytoreductive Surgery (CRS) and Hyperthermic Intra Peritoneal Chemotherapy (Hipec)

FAR-122

Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting

PoPuLAR